@article{article, title  = {{Mepolizumab for treating severe eosinophilic asthma: an evidence review group perspective of a NICE single technology appraisal}},

 publisher = {{Adis}},

 url = {{https://eprints.whiterose.ac.uk/id/eprint/121723 }},

 year = {{2017}},

 month = {{9}},

 author = {{Bermejo I and Stevenson M and Cooper K and Harnan S and Hamilton J and Clowes M and Carroll C and Harrison T and Saha S}},

 doi = {{10.1007/s40273-017-0571-8}},

 volume = {{36}},

 journal = {{Pharmacoeconomics}},

 pages = {{131-144}},

 note = {{Accessed on 2025/11/08}}}